A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Clinical trial NCT00621244 · COMPLETED
Trial details
- NCT number
- NCT00621244
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2009-12-03
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.